Nutraceutical International
This article was originally published in The Tan Sheet
Executive Summary
Park City, Utah-based supplement firm is the subject of a patent infringement suit by Swiss firm Lonza in New York district court for enteric preparations of L-carnitine L-tartarate. Lonza claims the U.S. Patent Office confirmed the validity of its patent "against an attack by an admitted infringer." Nutraceutical filed a complaint against Lonza in Utah district court March 2 for declaratory judgment of non-infringement, invalidity and non-enforceability of Lonza's patent. The firm estimates sales of the allegedly infringing carnitine products at less than 1% of FY 2003 sales...